N-linoleyltyrosine resisted the growth of non-small cell lung cancer cells via the regulation of CB(1) and CB(2) involvement of PI3K and ERK pathways

Background: N-linoleyltyrosine (NITyr), one of the anandamide analogs, exerts activity via the endocannabinoid receptors (CB(1) and CB(2)), which showed anti-tumor effects in various tumors. Therefore, we speculated that NITyr might show anti-non-small cell lung cancer (NSCLC) effects via the CB(1)...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yan, Zhao, Zhe, Liu, Yuan-Ting, Xu, Ze-Cheng, Li, Jing-Yi, Yang, Zheng-Yu, Rui-Wang, Yang, Yun-Qi, Zhang, Jia-Hui, Qiu, Si-Yuan, He, Tao, Wu, Yi-Ying, Liu, Sha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285528/
https://www.ncbi.nlm.nih.gov/pubmed/37361232
http://dx.doi.org/10.3389/fphar.2023.1164367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285528/
https://www.ncbi.nlm.nih.gov/pubmed/37361232
http://dx.doi.org/10.3389/fphar.2023.1164367

Ejemplares similares